Pre-, peri-, and postoperative management of chronic subdural hematomain and the role of antithrombotic and oral anticoagulant treatment on the development of recurrence and thromboembolic events, a retrospective study

Pre-, peri-, and postoperative management of chronic subdural hematomain and the role of antithrombotic and oral anticoagulant treatment on the development of recurrence and thromboembolic events, a retrospective study - Re-Co-cSDH

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025280

Enrollment

400

Registered

2021-06-15

Start date

2020-11-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I62.02 I74.9

Interventions

Group 1: Cohort of chronic subdural hematoma patients retrospectively collected between 2014 and 2020.

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Chronic subdural hematomas as confirmed on CT imaging (uni- or bilateral) treated by surgical evacuations either via twist drill craniostomy (TDC), single or double burr hole craniostomy (BHC) or bone flap craniotomy (BFC).

Exclusion criteria

Exclusion criteria: Patients < 18 years of age, prior causal neurosurgical or other potentially causal cranial procedures, causal intracranial hypotension i.e. shunt overdrainage and spinal dural leaks, acute subdural hematoma with a minor chronic components suggesting an acute hemorrhaging of chronic subdural hematoma membranes as the culprit.

Design outcomes

Primary

Measure	Time frame
Predictors of recurrence of chronic subdural hematoma.	—

Secondary

Measure	Time frame
Effects of seizing blood thining medication on the occurence of thromboembolic events around the treatment of chronic subdural hematomas. The effects of the internal architecture of hematomas on their recurrence rate and clinical outcome. The effects of pneumocephalus after surgical treatment of chronic subdural hematoma, on clinical outcome. The effects of epileptic seizures after surgical treatment of chronic subdural hematoma, on clinical outcome.	—

Measure

Time frame

Effects of seizing blood thining medication on the occurence of thromboembolic events around the treatment of chronic subdural hematomas. The effects of the internal architecture of hematomas on their recurrence rate and clinical outcome. The effects of pneumocephalus after surgical treatment of chronic subdural hematoma, on clinical outcome. The effects of epileptic seizures after surgical treatment of chronic subdural hematoma, on clinical outcome.

—

Countries

Germany

Contacts

Public ContactMichael Veldeman

Universitätsklinikum der RWTH Aachen

mveldeman@ukaachen.de00492418088481

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026